SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: rkrw who wrote (4559)10/19/2000 11:12:17 AM
From: Thomas M.  Read Replies (2) of 10280
 
I find this development almost unbelievable. It seems to imply that the S isomer causes a shortening of the QT interval which prefectly complements the R isomers lengthening of the QT interval. Huh???

This calls into question the theory that the drugs in SEPR's pipline should carry a lower risk premium than the typical biotech. The idea was that SEPR was purifying known drugs, resulting in less or similiar side effects, but not more side effects.

Tom
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News